Pharmaceutical Product Monograph: Cephalexin Capsules (250 mg / 500 mg)
In the pharmaceutical industry, Cephalexin is a foundational, first-generation Oral Cephalosporin. As a pharmacist and manufacturer, I view this molecule as the “Gram-Positive Workhorse”—it is technically designed to target the cell wall of staphylococci and streptococci, making it one of the most reliable and widely prescribed antibiotics in the world.
At your WHO-GMP facility in Mumbai, Cephalexin is likely a staple of your Primary Care & Pediatric portfolio. As of 2026, it remains a critical “narrow-spectrum” choice that helps reduce the risk of broader antibiotic resistance.
Therapeutic Profile: Primary Indications
Cephalexin is indicated for infections caused by susceptible isolates of specific Gram-positive and select Gram-negative bacteria.
| Indication | Clinical Context | Technical Rationale |
| Skin & Soft Tissue | Cellulitis / Abscesses | Gold Standard: Highly effective against S. aureus (MSSA) and S. pyogenes. |
| Genitourinary (UTI) | Cystitis / Prostatitis | High Urinary Excretion: 85–90% is excreted unchanged, achieving concentrations 1,000x higher in urine than serum. |
| Respiratory Tract | Pharyngitis / Tonsillitis | Used for Streptococci infections, especially when penicillin is not preferred. |
| Bone Infections | Osteomyelitis | Excellent bone penetration; often used as oral follow-up to IV therapy. |
| Otitis Media | ENT (Ear Infection) | Treats middle ear infections caused by S. pneumoniae and H. influenzae. |
Mechanism: Cell Wall Synthesis Disruption
Cephalexin works by sabotaging the “structural integrity” of the bacteria:
Binding: The molecule binds to Penicillin-Binding Proteins (PBPs) on the inner surface of the bacterial cell wall.
Enzyme Inhibition: It inhibits the transpeptidase enzyme, stopping the final cross-linking of the Peptidoglycan chains.
Lysis: Without these cross-links, the cell wall becomes mechanically unstable.
Bactericidal Action: Internal osmotic pressure causes the cell to swell and burst (Lysis).
The Pharmacist’s “Technical Warning”
The “QID” Schedule: Cephalexin typically has a short half-life ($1\text{–}1.5$ hours). It is traditionally dosed four times daily (every 6 hours) to maintain blood levels above the MIC.
Empty Stomach vs. Food: It can be taken with or without food. However, taking it on an empty stomach results in faster absorption and higher peak blood levels.
Penicillin Cross-Sensitivity: While safer than older cephalosporins, there is still a technical 1–10% risk of cross-reactivity in patients with a true penicillin allergy.
Probenecid Interaction: Taking Probenecid with Cephalexin can technically double its blood levels by slowing down its renal excretion.
The Manufacturer’s Perspective: Technical & Export
From a production and B2B standpoint at Healthy Life Pharma / Healthy Inc:
The “Pelletization” Advantage: For your capsules, highlight if you use Multi-particulate Pellets. This technology ensures more uniform gastric emptying and predictable absorption compared to traditional powder fills.
The “UTI Specialist” Market: As of 2026, there is a push to use Cephalexin as a “Quinolone-sparing” alternative for UTIs to reduce the use of Ciprofloxacin. Market this heavily to your B2B clinic clients.
Stability in Export: Cephalexin is relatively stable, but for Mumbai-based export, ensure your Alu-Alu or PVC/PVDC blisters are validated for “Zone IVb” conditions to prevent any moisture-induced degradation.
Dossier Support: We provide full WHO-standard CTD/eCTD Dossiers for Cephalexin 250/500 mg to support your registration in international B2B markets.